The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Lymphoma Research Foundation
New York, NY 10006
The Lymphoma Research Foundation of America (LRFA) and Cure for Lymphoma Foundation merged to become the Lymphoma Research Foundation. This is a national, voluntary, nonprofit organization dedicated to funding lymphoma research and providing comprehensive educational and support programs to increase awareness and knowledge of lymphoma nationwide. Lymphoma refers to cancer of the lymphatic system, which is a network of glands and vessels that circulate a thin, watery fluid known as lymph throughout the body. Lymphoma is classified into two major categories that are distinguished by cell type: Hodgkin's disease and non-Hodgkin's lymphoma. Both may be characterized by similar symptoms including night sweats, painless swelling of lymph nodes, fever, fatigue, itching, and weight loss. The foundation's primary mission is to fund lymphoma research at universities and cancer centers across the nation through annual research grants and fellowship awards. In addition, the LRFA provides a one-on-one "phone buddy support program" that matches affected individuals by cell type, stage and grade, or treatment plan; offers a lymphoma helpline that directs affected individuals and family members to cancer resources and clinical trial information; and conducts free support groups.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.